Amdocs Stock Financials

DOX
 Stock
  

USD 83.31  0.03  0.036%   

Amdocs Invested Capital is fairly stable at the moment as compared to the past year. Amdocs reported Invested Capital of 2.58 Billion in 2021. Invested Capital Average is likely to rise to about 2.8 B in 2022, whereas Net Income Per Employee is likely to drop slightly above 19.8 K in 2022.
  
Refresh
With this module, you can analyze Amdocs financials for your investing period. You should be able to track the changes in Amdocs individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Revenues

4.76 Billion

Share
Understanding current and past Amdocs Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amdocs' financial statements are interrelated, with each one affecting the others. For example, an increase in Amdocs' assets may result in an increase in income on the income statement.
The fundamental analysis of Amdocs is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Amdocs includes many different criteria found on its balance sheet. For example, investors should never minimize Amdocs' ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Amdocs' cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Amdocs.

Amdocs Limited Cash

Chance Of Financial Distress
Less than 6
Amdocs Limited has less than 6 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Amdocs stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Amdocs' official financial statements usually reflect Amdocs' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amdocs Limited. For example, before you start analyzing numbers published by Amdocs accountants, it's critical to develop an understanding of what Amdocs' liquidity, profitability, and earnings quality are in the context of the Technology space in which it operates.
Please note, the presentation of Amdocs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amdocs' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amdocs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amdocs Limited. Please utilize our Beneish M Score to check the likelihood of Amdocs' management to manipulate its earnings.

Amdocs Company Summary

Amdocs competes with Blackberry, Microsoft Corp, Allena Pharmaceuticals, JP Morgan, and Chevron Corp. Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people.
Specialization
Technology, Software - Infrastructure
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001062579
ISINGB0022569080
CUSIPG02602103
RegionEurope
LocationUnited Kingdom
Business AddressHirzel House, Smith
SectorTechnology
IndustrySoftware—Infrastructure
BenchmarkDOW
Websitewww.amdocs.com
Phone(44) 1481 728444
CurrencyUSD - US Dollar
You should never invest in Amdocs without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amdocs Stock, because this is throwing your money away. Analyzing the key information contained in Amdocs' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Amdocs Key Financial Ratios

Generally speaking, Amdocs' financial ratios allow both analysts and investors to convert raw data from Amdocs' financial statements into concise, actionable information that can be used to evaluate the performance of Amdocs over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Amdocs Limited reports annually and quarterly.

Amdocs Key Balance Sheet Accounts

201720182019202020212022 (projected)
Receivables971.5 M987.86 M861.03 M866.82 M780.14 M737.36 M
Accounts Payable194.74 M176.51 M110.14 M121.2 M139.38 M156.14 M
Total Assets5.35 B5.29 B6.34 B6.51 B7.49 B7.04 B
Current Assets1.72 B1.68 B2.07 B2.07 B1.86 B1.85 B
Assets Non Current3.63 B3.62 B4.27 B4.44 B5.11 B4.59 B
Cash and Equivalents519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Deferred Revenue132.41 M118.18 M126.84 M237.37 M272.98 M233.37 M
Shareholders Equity3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Total Liabilities1.86 B1.75 B2.68 B2.88 B3.31 B2.86 B
Current Liabilities1.29 B1.21 B1.22 B1.3 B1.5 B1.49 B
Tax Liabilities224.57 M207.51 M258.49 M304.54 M274.08 M263.65 M

Amdocs Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Amdocs' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201720182019202020212022 (projected)
Direct Expenses2.6 B2.65 B2.76 B2.81 B2.53 B2.34 B
Consolidated Income354.4 M479.45 M497.84 M688.37 M791.63 M673.75 M
Cost of Revenue2.6 B2.65 B2.76 B2.81 B3.23 B3.11 B
Gross Profit1.38 B1.43 B1.41 B1.48 B1.7 B1.65 B
Interest Expense6.77 M1.86 M11.44 M10.8 M12.42 M13.4 M
Net Income354.4 M479.45 M497.84 M688.37 M791.63 M673.75 M
Operating Expenses951.25 M863.75 M818.72 M878.98 M1.01 B997.35 M
Operating Income428.31 M569.75 M594.76 M598.69 M688.5 M653.52 M
Revenues3.97 B4.09 B4.17 B4.29 B4.93 B4.76 B
Income Tax Expense67.14 M88.44 M85.48 M125.93 M144.82 M119.14 M

Amdocs Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Amdocs Limited. It measures of how well Amdocs is doing because it can show the actual money that comes into and out of the company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Amdocs brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Amdocs had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Amdocs has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201720182019202020212022 (projected)
Capital Expenditure(231.15 M)(128.09 M)(205.51 M)(210.44 M)(189.39 M)(204.35 M)
Depreciation Amortization and Accretion211.22 M205.77 M198.41 M208.83 M240.15 M235.36 M
Net Cash Flow or Change in Cash and Cash Equivalents(230.83 M)52.85 M511.56 M(274.12 M)(315.24 M)(323.54 M)
Net Cash Flow Business Acquisitions and Disposals(355.14 M)(60.57 M)(249.36 M)146.29 M168.24 M181.52 M
Issuance Purchase of Equity Shares(337.95 M)(356.57 M)(263.06 M)(590.94 M)(531.85 M)(573.83 M)
Issuance Repayment of Debt Securities(20 M)(200 M)743.92 M(100 M)(115 M)(118.03 M)
Payment of Dividends and Other Cash Distributions(134.29 M)(147.62 M)(164.06 M)(177.47 M)(159.72 M)(172.33 M)
Net Cash Flow from Financing(425.69 M)(516.77 M)315.14 M(870.93 M)(1 B)(1.03 B)
Net Cash Flow from Investing(362.39 M)(86.76 M)(461.73 M)(329 M)(296.1 M)(319.48 M)
Net Cash Flow Investment Acquisitions and Disposals227.05 M101.29 M(753 K)(258.77 M)(232.9 M)(239.02 M)
Net Cash Flow from Operations557.25 M656.38 M658.14 M925.81 M1.06 B942.25 M
Share Based Compensation47.48 M38.55 M42.43 M54.25 M62.39 M56.9 M

Amdocs Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amdocs's current stock value. Our valuation model uses many indicators to compare Amdocs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amdocs competition to find correlations between indicators driving Amdocs's intrinsic value. More Info.
Amdocs Limited is one of the top stocks in operating margin category among related companies. It is one of the top stocks in return on equity category among related companies reporting about  0.98  of Return On Equity per Operating Margin. The ratio of Operating Margin to Return On Equity for Amdocs Limited is roughly  1.02 . Amdocs Operating Margin is fairly stable at the moment as compared to the past year. Amdocs reported Operating Margin of 16.05 in 2021. Comparative valuation analysis is a catch-all model that can be used if you cannot value Amdocs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amdocs' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amdocs' earnings, one of the primary drivers of an investment's value.

Amdocs Limited Systematic Risk

Amdocs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amdocs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Amdocs Limited correlated with the market. If Beta is less than 0 Amdocs generally moves in the opposite direction as compared to the market. If Amdocs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amdocs Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amdocs is generally in the same direction as the market. If Beta > 1 Amdocs moves generally in the same direction as, but more than the movement of the benchmark.
.

About Amdocs Financials

What exactly are Amdocs Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Amdocs' income statement, its balance sheet, and the statement of cash flows. Potential Amdocs investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Amdocs investors may use each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Amdocs is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Amdocs grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Amdocs Thematic Clasifications

Amdocs Limited is part of several thematic ideas from Israel Wall Street to Business Services. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Israel Wall Street Idea
Israel Wall StreetView
Business Services Idea
Business ServicesView
Software Idea
SoftwareView

Amdocs June 30, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Amdocs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amdocs Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amdocs Limited based on widely used predictive technical indicators. In general, we focus on analyzing Amdocs Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amdocs's daily price indicators and compare them against related drivers.
Downside Deviation1.31
Information Ratio0.13
Maximum Drawdown11.74
Value At Risk(2.18)
Potential Upside2.34
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.